Ultragenyx

Golfer devastated after just barely missing a putt

Biotech

Ultragenyx plans cost-cutting push after flunking phase 3 trials

Mereo BioPharma, which has European rights to the program, is planning to tightly control costs while evaluating the next steps.

Nick Paul Taylor Jan 2, 2026 5:37am

FDA

FDA plans real-time release of drug rejection letters

Sep 4, 2025 1:45pm

FDA stop sign

Fierce Pharma

FDA snubs Ultragenyx gene therapy over manufacturing issues

Jul 14, 2025 10:16am

Human skeleton in anatomy classroom

Lack of early win for Ultragenyx’s bone disorder med dents stock

Jul 10, 2025 8:04am

An illustration of a white strand of DNA which lies horizontally across an image

Ultragenyx tweaks gene therapy dosing to dial up efficacy

Oct 4, 2024 8:46am

Go sign green light

Ultragenyx gets green light to seek FDA approval of gene therapy

Jun 13, 2024 5:55am